Medicago Sativa Whole Chicory Root
Generic Name: medicago sativa whole chicory root
Brand Names:
Gout Relief 3310-s
This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Overview
This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Uses
Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus
Dosage
The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;
Warnings
For your health, please read the followingcarefully 1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product; 5. This product certainly has significant effect on gout,crystallization and hyperuricemia;
Frequently Asked Questions
What is Medicago Sativa Whole Chicory Root used for?▼
Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus
What are the important warnings for Medicago Sativa Whole Chicory Root?▼
For your health, please read the followingcarefully 1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product; 5. This product certainly has significant effect on gout,crystallization and hyperuricemia;
Related Medications
Belzutifan
belzutifan
Hypoxia-inducible Factor Inhibitor [EPC]
11 DESCRIPTION Belzutifan is an inhibitor of hypoxia-inducible factor-2α (HIF-2α). The chemical name of belzutifan is 3-[[(1S,2S,3R)-2,3-Difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluorobenzonitrile. The molecular formula is C 17 H 12 F 3 NO 4 S and the molecular weight is 383.34 Daltons.
Bevacizumab-maly
bevacizumab-maly
11 DESCRIPTION Bevacizumab-maly is a vascular endothelial growth factor inhibitor. Bevacizumab-maly is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-maly has an approximate molecular weight of 149 kDa. Bevacizumab-maly is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Isoniazid
isoniazid
Antimycobacterial [EPC]
DESCRIPTION Isoniazid, USP is an antibacterial available as 100 mg and 300 mg tablets for oral administration. Each tablet also contains as inactive ingredients: colloidal silicon dioxide, crospovidone, hydrogenated vegetable oil, microcrystalline cellulose, pregelatinized corn starch and talc. Isoniazid, USP is chemically known as isonicotinyl hydrazine or isonicotinic acid hydrazide. It has the following structural formula: C 6 H 7 N 3 O M.W.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.